Mon, Mar 2, 2015, 3:05 PM EST - U.S. Markets close in 55 mins.


% | $
Quotes you view appear here for quick access.

Medivation, Inc. (MDVN) Message Board

  • stockgeniussss stockgeniussss Feb 1, 2013 9:35 AM Flag

    Up 7% on poor numbers

    On February 1, 2013 in Tokyo, Japan (January 31, 2013 in San Francisco, CA), Medivation, Inc.'s alliance partner, Astellas Pharma Inc., reported its financial results for its third fiscal quarter ended December 31, 2012. Astellas reported, among other things, that net quarterly sales of XTANDI � (enzalutamide) capsules in the U.S., representing the first full quarter of U.S. XTANDI sales, were approximately $57 million. On November 1, 2012, in accordance with Tokyo Stock Exchange rules, Astellas provided guidance on anticipated net sales of XTANDI in the U.S. for its fiscal year ending March 31, 2013, which guidance was approximately $100 million. Based on the strong XTANDI sales performance in the quarter, Astellas now expects to exceed the estimated net sales provided in that guidance, but has not provided a specific estimate. Astellas' guidance with respect to future net sales of XTANDI is a forward-looking statement that involves a number of risks and uncertainties, many of which are outside of Astellas' control, including the degree of market acceptance of XTANDI, that could cause actual results to differ materially from projected results.

    Medivation is providing this information, which is taken directly from Astellas' public announcement, solely for the purpose of providing all of Medivation's investors with equal access to this third-party information. By providing this information from Astellas, Medivation does not in any way endorse or adopt these numbers or projections. Medivation is not providing any guidance regarding future sales of XTANDI and makes no comment regarding Astellas' guidance with respect to future net sales of XTANDI.

    LOL 60 M/Q not including tax and only 45% stake in drug = 25M/Q for MDVN - and these are the boom days :D.. Watch the CEO #$%$ your 4B in months

    Sentiment: Strong Sell

120.00+2.47(+2.10%)3:05 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.